Low-Dose Resveratrol Inhibits RIPK3-Mediated Necroptosis and Delays the Onset of Age-Related Hearing Loss
Background: To investigate the pathophysiology of age-related hearing loss (ARHL) and the mechanism of resveratrol (RSV) in prevention and treatment of ARHL.Methods: C57BL/6 mice of different ages were used in this study. Auditory brainstem response (ABR) was performed to assess hearing and identify...
Main Authors: | Zeyin Yang, Yan Zhang, Shuling Yang, Yongqing Ding, Yan Qu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.910308/full |
Similar Items
-
Transcriptome-Guided Identification of Drugs for Repurposing to Treat Age-Related Hearing Loss
by: Nick M. A. Schubert, et al.
Published: (2022-03-01) -
The Bcr-Abl inhibitor DCC-2036 inhibits necroptosis and ameliorates osteoarthritis by targeting RIPK1 and RIPK3 kinases
by: Longhuan Piao, et al.
Published: (2023-05-01) -
RIPK3-Dependent Necroptosis Is Induced and Restricts Viral Replication in Human Astrocytes Infected With Zika Virus
by: Chunxia Wen, et al.
Published: (2021-03-01) -
Mitochondrial Damage and Necroptosis in Aging Cochlea
by: Ah-Ra Lyu, et al.
Published: (2020-04-01) -
Roles of Key Ion Channels and Transport Proteins in Age-Related Hearing Loss
by: Parveen Bazard, et al.
Published: (2021-06-01)